Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa vs recFSH follow-up for FTET cycles
NCT01146418Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2010
- Primary completion
- Jul 2013
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
01
Overview
Phase 3, randomised, double-blind trial of corifollitropin alfa in infertility, sponsored by Organon & Co. Primary endpoint: Percentage of Participants With ≥1 Vital Pregnancy at 35 days. Started Jun 2010; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01146418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01146418.